Bod changes name to reflect focus on drug development and innovation by Steve Jones December 14, 2022December 14, 2022 Bod Australia has changed its name to Bod Science in a move to better reflect its […]
Bod strikes CBD over-the-counter deal with pharma firm Arrotex by Steve Jones December 2, 2022December 2, 2022
Cann Group looks to raise another A$10m for Mildura, puts Southern facility up for sale by Martin Lane October 25, 2022October 27, 2022
Bod set to launch CBG isolate via Special Access Scheme this month by Steve Jones October 19, 2022October 19, 2022
Bod spies ‘enormous potential’ of technology acquisition as pressure grows to generate revenue by Steve Jones October 13, 2022October 13, 2022
Company news: Bod Australia; Cann Group; MediCann Health; MGC Pharma; Wellnex Life by Steve Jones and Martin Lane October 5, 2022August 14, 2023
Bod reports decline in revenue and announces plan to acquire UK firm by Steve Jones September 1, 2022September 1, 2022
Company news: Bod; Neurotech International; Emyria; Creso Pharma by Martin Lane August 23, 2022August 23, 2022
Bod’s S3 registration candidate to go on sale through Special Access Scheme by Steve Jones June 27, 2022June 28, 2022